Nuzenio

Adalta

Adalta news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Australian company points to encouraging survival signal in mesothelioma CAR-T study - PharmaDispatchPharmaDispatch · Mon, 10 Aug 2026 05:46:59 GMT AdAlta Reports All Five Remaining EW-001 Mesothelioma Patients Still Alive at July 2026 Update - KalkineKalkine · Mon, 10 Aug 2026 02:34:07 GMT AdAlta’s EW-001 CAR-T Shows Promising Survival and Response in Advanced Mesothelioma - TipRanksTipRanks · Sun, 09 Aug 2026 23:48:55 GMT Adalta Ltd (ASX: 1AD) Share Price Review: Trading Data and Health Care Sector Context on August 7, 2026 - KalkineKalkine · Fri, 07 Aug 2026 07:20:00 GMT Mesothelioma Patient Remains Cancer-Free Two Years After Single CAR T Cell Treatment - Mesothelioma.netMesothelioma.net · Wed, 05 Aug 2026 15:29:01 GMT AdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatchBiotechDispatch · Wed, 05 Aug 2026 09:32:35 GMT AdAlta Reports Two-Year Survival Milestone for First EW-001 Complete Responder in Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:55:33 GMT AdAlta (ASX:1AD) Reports Two-Year Cancer-Free Survival Milestone in EW-001 Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:17:00 GMT

Timeline

Mon, 10 Aug 2026 05:46:59 GMTAustralian company points to encouraging survival signal in mesothelioma CAR-T study - PharmaDispatch

Mon, 10 Aug 2026 02:34:07 GMTAdAlta Reports All Five Remaining EW-001 Mesothelioma Patients Still Alive at July 2026 Update - Kalkine

Sun, 09 Aug 2026 23:48:55 GMTAdAlta’s EW-001 CAR-T Shows Promising Survival and Response in Advanced Mesothelioma - TipRanks

Fri, 07 Aug 2026 07:20:00 GMTAdalta Ltd (ASX: 1AD) Share Price Review: Trading Data and Health Care Sector Context on August 7, 2026 - Kalkine

Wed, 05 Aug 2026 15:29:01 GMTMesothelioma Patient Remains Cancer-Free Two Years After Single CAR T Cell Treatment - Mesothelioma.net

Wed, 05 Aug 2026 09:32:35 GMTAdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatch

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

CAR4 live mentions ASX4 live mentions Mesothelioma3 live mentions Mesothelioma Patients Still2 live mentions Alive2 live mentions July2 live mentions Kalkine AdAlta Reports2 live mentions T Shows Promising2 live mentions Survival2 live mentions Response2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Adalta.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.